Key result
The Wakabayashi & Daimon cardiometabolic index predicts ~48% higher cardiovascular disease risk.
Why the study?
The study was conducted to analyze the Wakabayashi & Daimon (2015) equation as a predictive indicator of cardiometabolic diseases and compare it with other indices.
Does the Wakabayashi & Daimon cardiometabolic index accurately predict the risk of cardiometabolic diseases in adults?
Population
11 selected articles evaluating adults with cardiometabolic diseases
Comparison
Wakabayashi & Daimon (2015) cardiometabolic index vs other indices or disease validation
Design
Systematic review
Authors
Loading...
CMI may aid risk stratification in primary care; confirms predictive validity across pooled studies.
Systematic Review
Does the Wakabayashi & Daimon cardiometabolic index accurately predict the risk of cardiometabolic diseases in adults?
Effect estimate: HR 1.48 (95% CI 1.33-1.65)
p-value: p=<0.001
The Wakabayashi & Daimon cardiometabolic index is a useful tool for identifying the risk of cardiometabolic diseases in adults.
Torres-Orozco et al. (2024) conducted a systematic review in Cardiometabolic diseases. Wakabayashi & Daimon cardiometabolic index (CMI) vs. Other indices was evaluated on Cardiovascular diseases (HR 1.48, 95% CI 1.33-1.65, p=<0.001). The Wakabayashi & Daimon cardiometabolic index is a valid predictive indicator for cardiometabolic diseases, significantly predicting cardiovascular disease risk (HR 1.48; 95% CI 1.33-1.65; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: